A company involved with Icahn Enterprises is progressing a pivotal clinical trial in its pharma portfolio.
1 report, 1 independent
Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company involved with Icahn Enterprises is progressing a pivotal clinical trial in its pharma portfolio.
Who's involved
What this event is mainly aboutIcahn EnterprisesVivus
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- StockStoryIEP Q2 Deep Dive: Diversified Operations Face Turnaround and Restructuring Hurdles Holding company and industrial conglomerate Icahn (NYSE:IEP) fell short of the market’s revenue expectations in Q2 C